Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Aspirin recalled?

Yes — there is an active recall. 4 ongoing FDA recalls mention Aspirin (59 total). Check the affected lots below.

Most common reason: cGMP deviation (14 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Aspirin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Aspirin recalls on record

none so far in 2026; 59 on record, newest first
Class II · Moderate risk

Aspirin Chewable tablet 81 mg

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Ongoing Packaging defect Safecor Health, LLC NDC 48433-129-01 D-0058-2025
Class I · High risk

Healthy Living Acetaminophen

Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

Ongoing Labeling / mix-up Aurobindo Pharma USA Inc NDC 58602-882-21 D-0641-2024
Class II · Moderate risk

HPC Tablet

CGMP Deviations

Terminated cGMP deviation ULTRAtab Laboratories, Inc. NDC 62969-242-00 D-0538-2022
Class II · Moderate risk

Low Dose ASPIRIN

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0170-2024
Class II · Moderate risk

Painaid

cGMP deviations

Terminated cGMP deviation Ultra Seal Corporation D-0492-2022
Class II · Moderate risk

Extra Strength Headache

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0391-2022
Class II · Moderate risk

Medique Pain-Off

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0390-2022
Class II · Moderate risk

Physicians CARE Extra Strength PAIN RELIEVER

CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.

Terminated cGMP deviation Medique Products D-0389-2022
Class III · Low risk

AERO Tab PAIN RELIEVER

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Terminated Stability / shelf life Ultra Seal Corporation D-0073-2022